Inventor · disambiguated record
Ronnie C. Mease
Also filed as: MEASE RONNIE · MEASE RONNIE C · MEASE RONNIE CHARLES
41 granted patents·23 pending applications·663 citations·filing 1989–2024
98Inventor score
Files withUNIV JOHNS HOPKINS48ASS UNIVERSITIES INC6BROOKHAVEN SCIENCE ASS LLC2POMPER MARTIN2CHANDRAN SACHIN S1
Top patents by PatentIndex Score
64 records- 0198US9226981B2PSMA-binding agents and uses thereofUNIV JOHNS HOPKINS·Filed 2014·Granted Jan 5, 2016·54 cites·16 claims
- 0298US8778305B2PSMA-binding agents and uses thereofPOMPER MARTIN·Filed 2009·Granted Jul 15, 2014·100 cites·18 claims
- 0397US9694091B2Labeled inhibitors of prostate specific membrane antigen (PSMA) biological evaluation, and use of imaging agentsUNIV JOHNS HOPKINS·Filed 2015·Granted Jul 4, 2017·19 cites·19 claims
- 0496US11661402B2PSMA-targeting compounds and uses thereofUNIV JOHNS HOPKINS·Filed 2022·Granted May 30, 2023·3 cites·19 claims
- 0596US11021450B2PSMA targeted fluorescent agents for image guided surgeryUNIV JOHNS HOPKINS·Filed 2020·Granted Jun 1, 2021·4 cites·21 claims
- 0696US9776977B2PSMA-targeting compounds and uses thereofUNIV JOHNS HOPKINS·Filed 2014·Granted Oct 3, 2017·14 cites·7 claims
- 0796US9056841B2PSMA-targeting compounds and uses thereofPOMPER MARTIN·Filed 2010·Granted Jun 16, 2015·48 cites·3 claims
- 0896US5021571ACyclohexyl EDTA monoanhydrideASS UNIVERSITIES INC·Filed 1989·Granted Jun 4, 1991·50 cites·1 claims
- 0995US10039845B2Labeled inhibitors of prostate specific membrane antigen (PSMA) biological evaluation, and use of imaging agentsUNIV JOHNS HOPKINS·Filed 2017·Granted Aug 7, 2018·7 cites·18 claims
- 1094US9044468B2Labeled inhibitors of prostate specific membrane antigen (PSMA), biological evaluation, and use as imaging agentsPOMPER MARTIN G·Filed 2008·Granted Jun 2, 2015·46 cites·4 claims
- 1193US9861713B2PSMA-binding agents and uses thereofUNIV JOHNS HOPKINS·Filed 2016·Granted Jan 9, 2018·9 cites·12 claims
- 1292US10736974B2Scaffolds and multifunctional intermediates for imaging PSMA and cancer therapyUNIV JOHNS HOPKINS·Filed 2015·Granted Aug 11, 2020·4 cites·1 claims
- 1392US10717750B268Ga-labeled NOTA-chelated PSMA-targeted imaging and therapeutic agentsUNIV JOHNS HOPKINS·Filed 2016·Granted Jul 21, 2020·4 cites·12 claims
- 1492US5639879AMacrocyclic polyaminocarboxylates for stable radiometal antibody conjugates for therapy, spect and pet imagingASS UNIVERSITIES INC·Filed 1995·Granted Jun 17, 1997·56 cites·1 claims
- 1592US2025177578A1Psma-binding agents and uses thereofUNIV JOHNS HOPKINS·Filed 2024·Application pending·0 cites
- 1691US10683272B2Metal/radiometal-labeled PSMA inhibitors for PSMA-targeted imaging and radiotherapyUNIV JOHNS HOPKINS·Filed 2015·Granted Jun 16, 2020·5 cites·20 claims
- 1791US10500292B2PSMA-binding agents and uses thereofUNIV JOHNS HOPKINS·Filed 2018·Granted Dec 10, 2019·6 cites·4 claims
- 1891US5428156ASynthesis of macrocyclic polyaminocarboxylates and their use for preparing stable radiometal antibody immunoconjugates for therapy, spect and pet imagingASS UNIVERSITIES INC·Filed 1993·Granted Jun 27, 1995·40 cites·2 claims
- 1990US9884132B2Homomultivalent and heteromultivalent inhibitors of prostate specific membrane antigen (PSMA) and uses thereofUNIV JOHNS HOPKINS·Filed 2016·Granted Feb 6, 2018·9 cites·13 claims
- 2089US10653806B2Homomultivalent and heteromultivalent inhibitors of prostate specific membrane antigen (PSMA) and uses thereofUNIV JOHNS HOPKINS·Filed 2018·Granted May 19, 2020·4 cites·8 claims
- 2189US10232058B2Prostate-specific membrane antigen-targeted photosensitizers for photodynamic therapyUNIV JOHNS HOPKINS·Filed 2014·Granted Mar 19, 2019·6 cites·14 claims
- 2288US9371360B2Homomultivalent and heteromultivalent inhibitors of prostate specific membrane antigen (PSMA) and uses thereofUNIV JOHNS HOPKINS·Filed 2012·Granted Jun 21, 2016·12 cites·5 claims
- 2387US11813340B2PSMA targeted radiohalogenated urea-polyaminocarboxylates for cancer radiotherapyUNIV JOHNS HOPKINS·Filed 2019·Granted Nov 14, 2023·2 cites·31 claims
- 2487US10947197B2Synthesis of the radiolabeled prostate-specific membrane antigen (PSMA) inhibitor [18F]DCFPyLUNIV JOHNS HOPKINS·Filed 2017·Granted Mar 16, 2021·3 cites·33 claims
- 2587US9422234B2Prostate specific membrane antigen (PSMA) targeted nanoparticles for therapy of prostate cancerCHANDRAN SACHIN S·Filed 2008·Granted Aug 23, 2016·14 cites·26 claims
- 2685US10369113B2Prostate specific membrane antigen (PSMA) targeted nanoparticles for therapy of prostate cancerUNIV JOHNS HOPKINS·Filed 2016·Granted Aug 6, 2019·4 cites·19 claims
- 2785US5334729AStable radiometal antibody immunoconjugatesASS UNIVERSITIES INC·Filed 1991·Granted Aug 2, 1994·30 cites·4 claims
- 2884US2025230135A1Metal/radiometal-labeled psma inhibitors for psma-targeted imaging and radiotherapyUNIV JOHNS HOPKINS·Filed 2024·Application pending·0 cites
- 2980US12070513B2PSMA-binding agents and uses thereofUNIV JOHNS HOPKINS·Filed 2021·Granted Aug 27, 2024·0 cites·23 claims
- 3080US5089663ACyclohexyl-triethylenetetraamine hexacetic acidASS UNIVERSITIES INC·Filed 1991·Granted Feb 18, 1992·20 cites·1 claims
- 3179US5635157ASynthesis of 4-substituted-trans-1,2-diaminocyclohexyl polyaminocarboxylate metal chelating agents for the preparation of stable radiometal antibody immunoconjugates for therapy and spect and pet imagingFiled 1993·Granted Jun 3, 1997·18 cites·17 claims
- 3279US2023348405A1Psma-targeting compounds and uses thereofUNIV JOHNS HOPKINS·Filed 2022·Application pending·0 cites
- 3378US12233137B1PSMA targeted radiohalogenated urea-polyaminocarboxylates for cancer radiotherapyUNIV JOHNS HOPKINS·Filed 2023·Granted Feb 25, 2025·0 cites·20 claims
- 3477US2025177580A1Psma targeted radiohalogenated urea-polyaminocarboxylates for cancer radiotherapyUNIV JOHNS HOPKINS·Filed 2024·Application pending·0 cites
- 3575US12065413B2PSMA targeted fluorescent agents for image guided surgeryUNIV JOHNS HOPKINS·Filed 2021·Granted Aug 20, 2024·0 cites·19 claims
- 3675US5292938ASynthesis of 4-substituted-trans-1, 2-diaminocyclohexyl polyaminocarboxylate metal chelating agents for the preparation of stable radiometal antibody immunoconjugates for therapy and spect and pet imagingASS UNIVERSITIES INC·Filed 1992·Granted Mar 8, 1994·33 cites·5 claims
- 3775US2024140971A1Psma targeted radiohalogenated ureas for cancer radiotherapyUNIV JOHNS HOPKINS·Filed 2023·Application pending·0 cites
- 3874US2025162993A1Synthesis of the radiolabeled prostate-specific membrane antigen (psma) inhibitor [18f]dcfpylUNIV JOHNS HOPKINS·Filed 2024·Application pending·0 cites
- 3974US2022135529A1Metal/radiometal-labeled psma inhibitors for psma-targeted imaging and radiotherapyUNIV JOHNS HOPKINS·Filed 2022·Application pending·0 cites
- 4074US2024150323A1Psma targeted fluorescent agents for image guided surgeryUNIV JOHNS HOPKINS·Filed 2023·Application pending·0 cites
- 4170US2020109124A1Psma targeted fluorescent agents for image guided surgeryThe Johns Hopkins Universt·Filed 2019·Application pending·0 cites
- 4270US2020282083A1Psma-binding agents and uses thereofUNIV JOHNS HOPKINS·Filed 2019·Application pending·0 cites
- 4369US11851407B2Synthesis of the radiolabeled prostate-specific membrane antigen (PSMA) inhibitor [18F]DCFPYLUNIV JOHNS HOPKINS·Filed 2021·Granted Dec 26, 2023·0 cites·34 claims
- 4467US11911488B2Scaffolds and multifunctional intermediates for imaging PSMA and cancer therapyUNIV JOHNS HOPKINS·Filed 2020·Granted Feb 27, 2024·0 cites·4 claims
- 4567US2020290982A1Metal/radiometal-labeled psma inhibitors for psma-targeted imaging and radiotherapyUNIV JOHNS HOPKINS·Filed 2020·Application pending·0 cites
- 4665US11814365B2PSMA targeted fluorescent agents for image guided surgeryUNIV JOHNS HOPKINS·Filed 2018·Granted Nov 14, 2023·0 cites·36 claims
- 4764US6022522ARigid bifunctional chelating agentsBROOKHAVEN SCIENCE ASS LLC·Filed 1998·Granted Feb 8, 2000·23 cites·1 claims
- 4862US2018009767A9Psma targeted fluorescent agents for image guided surgeryUNIV JOHNS HOPKINS·Filed 2017·Application pending·0 cites
- 4961US2021040126A168Ga-LABELED NOTA-CHELATED PSMA-TARGETED IMAGING AND THERAPEUTIC AGENTSUNIV JOHNS HOPKINS·Filed 2020·Application pending·0 cites
- 5057US11078166B2Triazole conjugated ureas, thioureas, carbamates, and reversed carbamates for PSMA-targeted imaging agents and uses thereofUNIV JOHNS HOPKINS·Filed 2016·Granted Aug 3, 2021·0 cites·1 claims
Showing the top 50 of 64 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →